Savaria Co. (TSE:SIS – Get Free Report) hit a new 52-week high on Friday after TD Securities raised their price target on the stock from C$27.00 to C$31.00. TD Securities currently has a buy rating on the stock. Savaria traded as high as C$26.42 and last traded at C$26.41, with a volume of 636433 shares. The stock had previously closed at C$24.32.
Several other research firms have also commented on SIS. Scotiabank boosted their price target on Savaria from C$25.00 to C$26.00 in a research report on Monday, November 10th. Stifel Nicolaus upped their price target on shares of Savaria from C$26.00 to C$28.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. Finally, National Bank Financial increased their target price on shares of Savaria from C$26.00 to C$30.00 in a research note on Monday, December 22nd. Six equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Savaria presently has a consensus rating of “Buy” and an average target price of C$27.33.
Read Our Latest Analysis on Savaria
Savaria Stock Performance
Savaria (TSE:SIS – Get Free Report) last announced its quarterly earnings results on Wednesday, March 4th. The company reported C$0.37 earnings per share (EPS) for the quarter. The company had revenue of C$241.78 million during the quarter. Savaria had a return on equity of 10.24% and a net margin of 6.90%. Analysts predict that Savaria Co. will post 1.2048518 EPS for the current year.
Savaria Company Profile
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Featured Articles
- Five stocks we like better than Savaria
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Your name isn’t on our protected list yet
- Elon Musk already made me a “wealthy man”
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
